|
US4304907A
(en)
*
|
1972-05-10 |
1981-12-08 |
The Upjohn Company |
Bicyclo lactone intermediates for prostaglandin analogs
|
|
US4353888A
(en)
|
1980-12-23 |
1982-10-12 |
Sefton Michael V |
Encapsulation of live animal cells
|
|
US4657866A
(en)
|
1982-12-21 |
1987-04-14 |
Sudhir Kumar |
Serum-free, synthetic, completely chemically defined tissue culture media
|
|
US4749620A
(en)
|
1984-02-15 |
1988-06-07 |
Massachusetts Institute Of Technology |
Encapsulated active material system
|
|
US4744933A
(en)
|
1984-02-15 |
1988-05-17 |
Massachusetts Institute Of Technology |
Process for encapsulation and encapsulated active material system
|
|
JPH0628570B2
(ja)
|
1986-02-13 |
1994-04-20 |
雪印乳業株式会社 |
カプセル体の製造方法及び装置
|
|
EP0301777A1
(en)
|
1987-07-28 |
1989-02-01 |
Queen's University At Kingston |
Multiple membrane microencapsulation
|
|
JPH04500909A
(ja)
|
1988-09-21 |
1992-02-20 |
アニマル バイオテクノロジー ケンブリッジ リミティド |
家畜からの多能性胚細胞系の誘導
|
|
US5089272A
(en)
|
1989-03-29 |
1992-02-18 |
Snow Brand Milk Products Co., Ltd. |
Process for producing capsules having a permeability-controllable membrane
|
|
US7037721B1
(en)
|
1990-01-29 |
2006-05-02 |
Hy-Gene Biomedical, Inc. |
Protein-free defined media for the growth of normal human keratinocytes
|
|
US5084350A
(en)
|
1990-02-16 |
1992-01-28 |
The Royal Institution For The Advance Of Learning (Mcgill University) |
Method for encapsulating biologically active material including cells
|
|
AU2882992A
(en)
|
1991-11-06 |
1993-06-07 |
Arthur A. Axelrad |
Cell culture medium
|
|
US5578442A
(en)
|
1992-03-23 |
1996-11-26 |
Vivorx, Inc. |
Graft copolymers of polycationic species and water-soluble polymers, and use therefor
|
|
US5340740A
(en)
|
1992-05-15 |
1994-08-23 |
North Carolina State University |
Method of producing an avian embryonic stem cell culture and the avian embryonic stem cell culture produced by the process
|
|
US5453357A
(en)
|
1992-10-08 |
1995-09-26 |
Vanderbilt University |
Pluripotential embryonic stem cells and methods of making same
|
|
US7153684B1
(en)
|
1992-10-08 |
2006-12-26 |
Vanderbilt University |
Pluripotential embryonic stem cells and methods of making same
|
|
US5766951A
(en)
|
1992-11-12 |
1998-06-16 |
Quality Biological, Inc. |
Serum-free medium supporting growth and proliferation of normal bone marrow cells
|
|
SG48813A1
(en)
|
1993-08-12 |
1998-05-18 |
Cytotherapeutics Inc |
Improved composition and methods for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules
|
|
US6037174A
(en)
|
1993-08-23 |
2000-03-14 |
Nexell Therapeutics, Inc. |
Preparation of serum-free suspensions of human hematopoietic cells or precursor cells
|
|
US5409813A
(en)
|
1993-09-30 |
1995-04-25 |
Systemix, Inc. |
Method for mammalian cell separation from a mixture of cell populations
|
|
US6432711B1
(en)
|
1993-11-03 |
2002-08-13 |
Diacrin, Inc. |
Embryonic stem cells capable of differentiating into desired cell lines
|
|
FR2726003B1
(fr)
|
1994-10-21 |
2002-10-18 |
Agronomique Inst Nat Rech |
Milieu de culture de cellules embryonnaires totipotentes aviaires, procede de culture de ces cellules, et cellules embryonnaires totipotentes aviaires
|
|
US5874301A
(en)
|
1994-11-21 |
1999-02-23 |
National Jewish Center For Immunology And Respiratory Medicine |
Embryonic cell populations and methods to isolate such populations
|
|
US5914268A
(en)
|
1994-11-21 |
1999-06-22 |
National Jewish Center For Immunology & Respiratory Medicine |
Embryonic cell populations and methods to isolate such populations
|
|
US5843780A
(en)
|
1995-01-20 |
1998-12-01 |
Wisconsin Alumni Research Foundation |
Primate embryonic stem cells
|
|
US5908782A
(en)
|
1995-06-05 |
1999-06-01 |
Osiris Therapeutics, Inc. |
Chemically defined medium for human mesenchymal stem cells
|
|
US6190910B1
(en)
|
1996-05-21 |
2001-02-20 |
The Institute Of Physical And Chemical Research |
Mouse embryonic stem cell lines
|
|
US5945337A
(en)
|
1996-10-18 |
1999-08-31 |
Quality Biological, Inc. |
Method for culturing CD34+ cells in a serum-free medium
|
|
WO1998059035A2
(en)
|
1997-06-25 |
1998-12-30 |
The Goverment Of The United States Of America, Represented By The Secretary, Dept. Of Health And Human Services, National Institutes Of Health |
Serum-free cell growth medium
|
|
CA2348687A1
(en)
|
1998-11-09 |
2000-05-18 |
Consorzio Per La Gestione Del Centro Di Biotecnologie Avanzate |
Serum free medium for chondrocyte-like cells
|
|
US6875607B1
(en)
|
1998-11-09 |
2005-04-05 |
Es Cell International Pte Ltd |
Embryonic stem cells
|
|
WO2001011011A2
(en)
*
|
1999-08-05 |
2001-02-15 |
Mcl Llc |
Multipotent adult stem cells and methods for isolation
|
|
US8075881B2
(en)
*
|
1999-08-05 |
2011-12-13 |
Regents Of The University Of Minnesota |
Use of multipotent adult stem cells in treatment of myocardial infarction and congestive heart failure
|
|
US8609412B2
(en)
*
|
1999-08-05 |
2013-12-17 |
Regents Of The University Of Minnesota |
Mapc generation of lung tissue
|
|
US7015037B1
(en)
*
|
1999-08-05 |
2006-03-21 |
Regents Of The University Of Minnesota |
Multiponent adult stem cells and methods for isolation
|
|
WO2002064748A2
(en)
|
2001-02-14 |
2002-08-22 |
Furcht Leo T |
Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
|
|
US20060003323A1
(en)
*
|
2000-03-01 |
2006-01-05 |
John Alsobrook |
Therapeutic polypeptides, nucleic acids encoding same, and methods of use
|
|
EP2298867A3
(en)
|
2000-06-20 |
2013-01-16 |
ES Cell International Pte Ltd. |
Method of controlling differentiation of embryonic stem (ES) cells by culturing ES cells in the presence of bmp-2 pathway antagonists
|
|
US8039261B2
(en)
*
|
2000-11-17 |
2011-10-18 |
Vascular Biogenics Ltd. |
Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
|
|
US8071740B2
(en)
*
|
2000-11-17 |
2011-12-06 |
Vascular Biogenics Ltd. |
Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
|
|
EP1421181A1
(en)
|
2001-08-23 |
2004-05-26 |
Reliance Life Sciences Pvt., Ltd. |
ISOLATION OF INNER CELL MASS FOR THE ESTABLISHMENT OF HUMAN EMBRYONIC STEM CELL (hESC) LINES
|
|
US9969980B2
(en)
|
2001-09-21 |
2018-05-15 |
Garnet Biotherapeutics |
Cell populations which co-express CD49c and CD90
|
|
US6703279B2
(en)
|
2002-01-04 |
2004-03-09 |
Promos Technologies, Inc. |
Semiconductor device having contact of Si-Ge combined with cobalt silicide
|
|
EP1478734A4
(en)
|
2002-01-25 |
2006-04-05 |
Genzyme Corp |
NON-SERUM MEDIUM FOR CHONDROCYTES AND METHODS OF USE THEREOF
|
|
US7145057B2
(en)
|
2002-02-01 |
2006-12-05 |
Origen Therapeutics, Inc. |
Chimeric bird from embryonic stem cells
|
|
WO2003077841A2
(en)
*
|
2002-03-12 |
2003-09-25 |
The General Hospital Corporation |
Use of signal transduction inhibitors and combination therapies for the prevention or treatment of cancer and angiogenesis related diseases
|
|
US20030199464A1
(en)
*
|
2002-04-23 |
2003-10-23 |
Silviu Itescu |
Regeneration of endogenous myocardial tissue by induction of neovascularization
|
|
GB0221481D0
(en)
|
2002-09-16 |
2002-10-23 |
Richards John M |
Grip for hand held instruments
|
|
AU2003287444A1
(en)
*
|
2002-10-31 |
2004-05-25 |
The General Hospital Corporation |
Repairing or replacing tissues or organs
|
|
JP2005065661A
(ja)
*
|
2003-08-20 |
2005-03-17 |
Akihiro Yamaguchi |
ヒト血管内皮細胞のＶＥＧＦ誘導性活性化及び血管新生におけるＩｄの役割
|
|
FR2893252B1
(fr)
*
|
2005-11-17 |
2008-02-15 |
Engelhard Lyon Sa |
Extraits vegetaux stimulant has2
|
|
CN104027359A
(zh)
*
|
2006-01-23 |
2014-09-10 |
阿特西斯公司 |
无附加的免疫抑制治疗的mapc治疗法
|
|
US20070253937A1
(en)
*
|
2006-04-26 |
2007-11-01 |
Young-Sup Yoon |
Novel multipotent stem cells and use thereof
|
|
EP2023961B1
(en)
*
|
2006-05-17 |
2016-02-24 |
Andrea Banfi |
Method for isolating homogeneous populations of transduced progenitors stably expressing specific levels of a transgene
|
|
US20090053182A1
(en)
*
|
2007-05-25 |
2009-02-26 |
Medistem Laboratories, Inc. |
Endometrial stem cells and methods of making and using same
|
|
WO2011011500A1
(en)
*
|
2009-07-21 |
2011-01-27 |
Abt Holding Company |
Use of stem cells to reduce leukocyte extravasation
|